0378-5437 : Memantine Hydrochloride 21 mg Oral Capsule, Extended Release


NDC: 0378-5437
Labeler: Mylan Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Memantine Hydrochloride
Dosage Form: Oral Capsule, Extended Release
Application #: ANDA206032
Rev. Date: 


Appearance:


Markings: MYLAN;MT;21
Shapes:  Capsule
Colors:  White / Green
Size (mm): 16
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0378-5437-93: 30 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (0378‑5437‑93)

Active Ingredients:

  • Memantine Hydrochloride

Dosage Strength:

  • 21 mg

Inactive Ingredients:

  • Starch, Corn
  • Ethylcellulose, Unspecified
  • Gelatin, Unspecified
  • Hypromellose, Unspecified
  • Hydroxypropyl Cellulose, Unspecified
  • Sodium Lauryl Sulfate
  • Sucrose
  • Talc
  • Titanium Dioxide
  • Ferric Oxide Yellow
  • Ammonia
  • Ferrosoferric Oxide
  • Propylene Glycol
  • Shellac
  • Fd&c Blue No. 2 /

Pharmaceutical Classes:

  • NMDA Receptor Antagonists [MoA]
  • N-methyl-D-aspartate Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0378-1103 Memantine Hydrochloride 5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-1104 Memantine Hydrochloride 10 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-5435 Memantine Hydrochloride 7 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-5436 Memantine Hydrochloride 14 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-5438 Memantine Hydrochloride 28 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0121-0850 Memantine Hydrochloride 10 mg/5ml Oral Solution by Pharmaceutical Associates, Inc.
  • 0527-1221 Memantine Hydrochloride 5 mg Oral Tablet by Lannett Company, Inc.
  • 0527-1222 Memantine Hydrochloride 10 mg Oral Tablet by Lannett Company, Inc.
  • 0527-1943 Memantine Hydrochloride 2 mg/ml Oral Solution by Lannett Company, Inc.
  • 0591-3011 Memantine Hydrochloride 2 mg/ml Oral Solution by Actavis Pharma, Inc
  • 0591-3870 Memantine Hydrochloride 5 mg Oral Tablet by Actavis Pharma, Inc
  • 0591-3875 Memantine Hydrochloride 10 mg Oral Tablet by Actavis Pharma, Inc
  • 0591-3900 Memantine Hydrochloride Oral Kit by Actavis Pharma, Inc
  • 0615-8264 Memantine Hydrochloride 28 mg Oral Capsule, Extended Release by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0832-1112 Memantine Hydrochloride 5 mg Oral Tablet, Film Coated by Upsher-smith Laboratories, Inc
  • 0832-1113 Memantine Hydrochloride 10 mg Oral Tablet, Film Coated by Upsher-smith Laboratories, Inc
  • 0904-6734 Memantine Hydrochloride 7 mg Oral Capsule, Extended Release by Major Pharmaceuticals
  • 0904-6735 Memantine Hydrochloride 28 mg Oral Capsule, Extended Release by Major Pharmaceuticals
  • 0904-6736 Memantine Hydrochloride 14 mg Oral Capsule, Extended Release by Major Pharmaceuticals
  • 0904-6737 Memantine Hydrochloride 21 mg Oral Capsule, Extended Release by Major Pharmaceuticals
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0378-5437 QR Code

< Prev: 0378-5436Next: 0378-5438 >

Related Discussions:

namenda memantine hci light blue oval with fl other side 10
Message: I found in my boyfriends pants while washing clothes.i asked where he got it from he said a friend if his.what ... 1 reply
Memantine Hydrochloride Tablets
THE SHORTEST NAME ON TEN TABLET SLIP INDICATED AS admenta5. exactly what action of this tablet I want to know...
memantine interaction
memantine interactions with benzodiazepines...
Namenda (memantine)
...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.